Biden calls on Con­gress to al­low Medicare drug price ne­go­ti­a­tions

Over­shad­owed by Pres­i­dent Biden’s vac­cine man­date an­nounce­ment, the ad­min­is­tra­tion ear­li­er in the day re­leased its top pri­or­i­ties for drug pric­ing re­forms mak­ing their way through Con­gress.

The re­forms are slat­ed to save the gov­ern­ment hun­dreds of bil­lions to off­set oth­er spend­ing pri­or­i­ties.

The 29-page HHS re­port makes clear the ad­min­is­tra­tion’s strong de­sire for any leg­is­la­tion to in­clude Medicare drug price ne­go­ti­a­tions — an idea the phar­ma­ceu­ti­cal in­dus­try strong­ly op­pos­es — as well as mea­sures to slow price in­creas­es over time on ex­ist­ing drugs.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER